Actuate Therapeutics Inc
ACTU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $3 | $3 | $4 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $6 | $6 | $7 |
| Operating Income | -$5 | -$6 | -$6 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$5 | -$6 | -$6 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS | -0.25 | -0.3 | -0.32 | -0.6 |
| % Growth | 16.7% | 6.3% | 46.7% | – |
| EPS Diluted | -0.25 | -0.3 | -0.32 | -0.6 |
| Weighted Avg Shares Out | 21 | 20 | 19 | 20 |
| Weighted Avg Shares Out Dil | 21 | 20 | 19 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |